Management Team2018-02-13T21:39:44+00:00

Management Team

Said Sebti, PhD
Chief Scientific Officer

  • Professor and Chair, Department of Drug Discovery – Moffitt Cancer Center
  • Co-inventor of PTX-100 & PTX-200
  • Named among top 20 Translational Researchers in the world by Nature Publishing Group

Terry Chew, M.D.
Chief Medical Officer

  • Hematologist/oncologist with 20 years experience in biotech & pharma
  • 5 New Drug Applications including DaunoXome, Taxotere and DepoCyte
  • PTX is only 1 of only 2 ASX biotechs with a CMO that has successfully approved drugs

Mark Sonnemann, JD
VP – Clinical Operations

  • Extensive experience in all phases of clinical research, particularly in early phase drug development
  • Regulatory and quality assurance experience in pharmaceutical, biotech, and medical devices
  • Diverse background in clinical research, transplant, and law

Mike Preigh, PhD

  • Led CMC at Array BioPharma for 10 years
  • Successfully brought >20 drug candidates to IND & clinical development
  • Previously Pfizer

Claudia Gregorio-King, PhD
VP – Operations

  • Extensive experience in the management of pre-clinical and clinical research and intellectual property
  • Regulatory affairs and clinical project management experience with small and large CROs

Chaline Strickland, Pharm.D.
Regulatory Affairs

  • Senior Director of Clinical Affairs at Ground Zero Pharmaceuticals
  • Involved in dozens of New Drug Applications